Completed NA INTERVENTIONAL 1-arm NCT01125137

Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar

Sponsor: Henry Ford Health System

Conditions Keloid

Updated 6 times since 2017 Last updated: Apr 29, 2024 Started: Feb 28, 2010 Primary completion: Jan 31, 2011 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01125137, this NA trial focuses on Keloid and remains completed. Sponsored by Henry Ford Health System, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2024 — Jul 2024 [monthly]

Completed NA
Jan 2021 — May 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Henry Ford Health System

Data source: Henry Ford Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Detroit, United States